MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HR-05-0005125
Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals Private Limited - pharma in Gurgaon, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.07 Lakh
▼ 41% YoY
Net loss · FY 2025
₹577
Net margin -0.1%
EBITDA · FY 2025
₹12,218
EBITDA margin 1.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Elixir Pharmaceuticals Private Limited
Data last updated:
Elixir Pharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100HR2020PTC087947. Its GSTIN is 09AAGCE0088F1ZO (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Kumar Agarwal and Vishal Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Adani Oyster Grande Flat No D – 102 Opp. Delhi Public School Sector – 102, Gurgaon, Haryana, India – 122001.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.07 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹577 (net margin -0.1%) and EBITDA of ₹12,218 (EBITDA margin 1.3%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years.
Elixir Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0005125).
Company Details of Elixir Pharmaceuticals Private Limited
CIN U85100HR2020PTC087947
Registration Number 087947
Incorporation Date 29 July 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-05-0005125
Recognitions & Rankings of Elixir Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Adani Oyster Grande Flat No D – 102 Opp. Delhi Public School Sector – 102, Gurgaon, Haryana, India – 122001
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Elixir Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Elixir Pharmaceuticals Private Limited
The main business activity of Elixir Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elixir Pharmaceuticals Private Limited FY 2025 filings available
Elixir Pharmaceuticals Private Limited reported revenue of ₹9.07 Lakh (down 41% YoY) for FY 2025.
Revenue · FY 2025
₹9.07 Lakh ▼ 41%
Net loss · FY 2025
₹577 margin -0.1%
EBITDA · FY 2025
₹12,218 margin 1.3%
Compounded Annual Growth Rate (CAGR) of Elixir Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▼ 61%
3 years · compounded
▼ 28%
Revenue has declined at a compounded annual rate (CAGR) of 11% over three years, including a 41% fall in the latest year. EBITDA fell 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elixir Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12,218 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹577 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elixir Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elixir Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Kumar Agarwal | Director | 29 Jul 2020 | 6 Years 2 Months | Current |
| Vishal Agarwal | Director | 29 Jul 2020 | 6 Years 2 Months | Current |
Peer Comparison of Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healthon Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2016) | •••• | •••• | 9.0% | •••• | Kochi, Kerala, India |
| Atbu Harita Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Vyara, Gujarat, India |
| Livway Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2025) | •••• | •••• | 33.0% | •••• | Delhi, India |
| Adils Pharmaceuticals Private Limited | ₹9.11 Lakh (FY 2024) | •••• | •••• | -15.0% | •••• | Lucknow, Uttar Pradesh, India |
| Hari Cure Pharmaceuticals Private Limited | ₹9.07 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Patna, Bihar, India |
| Elixir Pharmaceuticals Private Limited this company | ₹9.07 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Gurgaon, Haryana, India |
| Freefind Pharmaceuticals Private Limited | ₹9.07 Lakh (FY 2024) | •••• | •••• | •••• | Aligarh, Uttar Pradesh, India | |
| Triozone Pharmaceuticals Private Limited | ₹9.05 Lakh (FY 2019) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Bhartiya Pharmaceuticals India Private Limited | ₹9.05 Lakh (FY 2016) | •••• | •••• | 779.0% | •••• | Indore, Madhya Pradesh, India |
| Soxil Drugs and Pharmaceuticals Pvt Ltd | ₹9.03 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Ajmer, Rajasthan, India |
| Lifesource Pharmaceuticals Private Limited | ₹9.03 Lakh (FY 2025) | •••• | •••• | 15.0% | •••• | Mumbai Dt 6 2, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Elixir Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals Private Limited is audited by ANANT AGARWAL & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANANT AGARWAL & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Elixir Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals Private Limited has a workforce of 0 employees as of Mar 03, 2025.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Prashant Kumar Agarwal was appointed as Director on 29 Jul 2020.
AGM
Elixir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elixir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Prashant Kumar Agarwal was appointed as Director.
Appointed
Vishal Agarwal was appointed as Director.
Incorporation
29 Jul 2020
Elixir Pharmaceuticals Private Limited was registered on 29 Jul 2020 with Roc Delhi & aged 6 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Elixir Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elixir Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elixir Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCE0088F1ZO | Uttar Pradesh | Active | 27 Oct 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elixir Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elixir Pharmaceuticals Private Limited
Elixir Pharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 July 2020 (6+ years old) and is registered under CIN U85100HR2020PTC087947.
Elixir Pharmaceuticals reported revenue of ₹9.07 Lakh for FY 2025 (down 41% YoY).
Elixir Pharmaceuticals has 2 current directors:
- Prashant Kumar Agarwal - Director
- Vishal Agarwal - Director
Elixir Pharmaceuticals reported a net loss of ₹577 (net margin -0.1%) and EBITDA of ₹12,218 (EBITDA margin 1.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Elixir Pharmaceuticals is -11% over three years. In the latest year (FY 2025) revenue fell 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Elixir Pharmaceuticals is 09AAGCE0088F1ZO, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Elixir Pharmaceuticals is U85100HR2020PTC087947. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elixir Pharmaceuticals was incorporated on 29 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Elixir Pharmaceuticals by revenue are Healthon Pharmaceuticals Private Limited, Atbu Harita Pharmaceuticals Private Limited, Livway Pharmaceuticals Private Limited, Adils Pharmaceuticals Private Limited, Hari Cure Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Prashant Kumar Agarwal was appointed as Director on 29 Jul 2020. Vishal Agarwal was appointed as Director on 29 Jul 2020.
Yes, Elixir Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0005125).